Physician profile
Christopher A George
NPI 1437308335
$2,831.68
in general payments reported to CMS, 2019-2025
12 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $13.84 · 2021: $107 · 2022: $211 · 2023: $382 · 2024: $132 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907 · Travel and Lodging: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.68 |
| Travel and Lodging | $241.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $964.17 | 2019-2025 | Alphavent, 1788, Mako |
| Karl Storz Endoscopy-America | $762.27 | 2019 | |
| Smith+Nephew, INC. | $447.73 | 2019-2023 | Lens 4k, Bioinductive Implant With Arthroscopic Delivery System - Medium, Microaire |
| Pacira Pharmaceuticals Incorporated | $192.21 | 2022-2025 | Exparel |
| Pacira Therapeutics, INC. | $160.09 | 2019-2021 | |
| Depuy Synthes Sales INC. | $85.98 | 2022-2025 | Monovisc, Orthovisc |
| Ethicon US, LLC | $58.75 | 2019 | |
| Radius Health, INC. | $55.18 | 2019-2025 | Tymlos |
| Heron Therapeutics, INC. | $42.51 | 2024-2025 | Zynrelef |
| Bioventus LLC | $33.43 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Axogen | $16.24 | 2019 | |
| Convatec INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.